Source: International Congress 2019 – Insights into physiological diagnostic services
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Altrip (Cambridge, United Kingdom), K. Sylvester (Cambridge, United Kingdom), R. Mahadeva (Cambridge, United Kingdom), J. Carter (Cambridge, United Kingdom), M. Haines (Cambridge, United Kingdom), J. Walsh (Cambridge, United Kingdom), J. Foord (Cambridge, United Kingdom). On the temporal characterisation of novel capnometric indices for personalised monitoring and treatment optimisation of COPD. 3920

Member's Comments

No comment yet.

Related content which might interest you: A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 Novel ventilatory and monitoring approaches Source: Annual Congress 2007 - PG3 - Respiratory failure: ABC of noninvasive and invasive mechanical ventilation Year: 2007 Chronious: A new wearable monitoring system for COPD patients Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 A novel simple internet-based system for real time monitoring and optimizing home mechanical ventilation Source: Annual Congress 2008 - Noninvasive ventilation in the chronic setting Year: 2008 Recommended approaches to minimize aerosol dispersion of COVID during noninvasive ventilatory support can deteriorate ventilator performances: a benchmark comparative study Source: Virtual Congress 2021 – New trends in non-invasive respiratory support Year: 2021 Patient-ventilator interaction during noninvasive ventilation: practical assessment and theoretical basis Source: Breathe 2009; 5: 322-333 Year: 2009 Population segmentation to identify priority targets for identification and behaviour change interventions in COPD Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011 A simple algorithm for the identification of clinical COPD phenotypes Source: Eur Respir J, 50 (5) 1701034; 10.1183/13993003.01034-2017 Year: 2017 Smartphone-based cough detection predicts asthma control – description of a novel, scalable digital biomarker Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020 A NMR-based metabolomics approach to the assessment of inhaled pharmacotherapy in patients with COPD Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Features of asthma management: quantifying the patient‘s perspective using discrete choice modelling Source: Eur Respir J 2006; 28: Suppl. 50, 122s Year: 2006 Comparison of multidimensional assessment systems with regard to risk prediction for exacerbations of COPD Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Blood biomarker algorithms to guide COPD assessment and risk stratification Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 A network-based approach to defining phenotypes in COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 A novel approach to the analysis of ambulatory 24hr cough monitoring data Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021 The concept of control in COPD: a new proposal for optimising therapy Source: Eur Respir J 2014; 44: 1072-1075 Year: 2014 Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Clinical feasibility study utilizing multi-sensor devices with the goal of developing remote monitoring digital health solutions for patients with asthma or COPD Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine Year: 2020